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Post-riceptar activation in vitro 
A. new poten~~or of insulin &Son, s-[4-~1_mhy~~y~~ohexyim;et~ox~~~~~l~~h~~o~~dine-~~~~~~~~ w&% 
tested’for activation of insulin action In vitro. The agent (50 mg . kg -’ h day- ‘) was orally administered to 
rats for 14 days and adipocytes from treated rats were used to assess insulin-binding, glucose uptake and 
glucose oxidation. In obese rats, tht; &@nt increased glucose uptake and oxidation without any change in 
Eas~ulin binding, whereas in lean or $t~~~tozotoc~n-seated rats it failed to iruxease ghscose metabolism, Fat 
tikres were cuhured with.the agent for 24 h and were tested for insulin action. In the presence of insulin 
(l~‘~~~rnl~ in the cuiture media; the agent increased glucose oxidation in these celis without any change 
in insuhn binding. However, without h&&r in the culture media the agent did not increase glucose 
ox~~r~on_ Thus, the agent ~~~~~~~d to note&ate insulin action at the post receptor process. 
1 e INTIKXXJCTION 
Various agents in~~udi~~ ~1~~~~~ urea and 
bigumides have been used for alleviation of 
glucose i~t~~~r~~~ in diabetes mehitus. These 
agents appeared to increase gkm~~~e ~~~~~rn by 
~~t~~~~~~t~~ ar pancreatic effects Ii&& Pur- 
t~ermor~~ t e~.~~~ proved to ~o~e~t~ate insulin 
a&ion in tiyo g3] and in vitro f4] when insulin is 
present, Some of these agents are reported to in- 
crme insulin receptor capacity which may con- 
trjbute to potentiate insulin action [5,6]” 
W@ report here that a new chemical agent, 
S~[~~(~~m~thylcyclohexylmetho~y)b~~~~~~thiazoli- 
din&&&&one (ADD-3878 or ADD) can potentiate 
insulin action in rat adipocytes without. any change 
in insulin receptors and that this agent itself does 
not possess insulin-like activity. R&G agent may be 
useful for ~eatment of Type-II diabetes melIit~~ 
with irXRased insrtfirr resistance and byperin- 
~~li~~rni~ by potentiati~ insulin a&% 
2. MATBRIAIS AND METHODS 
5-j4-(1-~~tJrylcyclohexylmethoxy)~~~~~l~t~~~~ 
zolidine-2,4-dione (ADD-3878) was &err&&y 
synthesized (Q.1) and was supplied by Takeda 
Chemical I~~~tr~~ (Osaka). Porcine insulin (Lot 
1Pf91, 2&2 ~~~t~~rng) waskindly supplies by Bli 
Lilly, Nat’% was purchase from New England 
Nucfear and culture medium TCM 199 fram Gib- 
co. Bovine serum albumin (fraction V) was pur- 
chased from Armour P~arrna~~ti~~~~ olI~~e~~~e 
from Wdrthington Biochemicals, 2-deoxy- 
[l-14C]glucosc, C-[14C]glucose and D-[I-%]- 
gluc sefrom New England Nuclear. 
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ADD-3878 (50 mg . kg-’ . day-‘) in saline was 
orally administered to3 groups of Sprague-Dawley 
rats (lean young rats, 160-170 g, obese old rats, 
390-415 g and (55 mg/kg) streptozotocin-treated 
rats, 170-185 g) for 14 days. The weight-matched 
controls were similarly treated with saline. Rats 
were then killed and adipocytes from epidid~~ 
tissues were isolated by collagenase and were used 
for insulin-binding and glucose metabolism 
studies. The methods of insulin-binding, glucose 
uptake and glucose oxidation studies were as in 
[7,8]. Insulin-binding was performed at 37’C for 
45 min in the buffer containing bacitracin 
50 mglml, pH 7.4. Iodination of insulin was per- 
formed as in 191 and the specific activity of the 
iodinated insulin was 100-150 pCi/pg. 
In order to directfy determine in vitro action of 
ADD-3878 to potentiate insulin action, adipose 
tissues (about 10 mg/piece) were cultured with 
ADD-3878 in TCM 199 medium with 5”10 bovine 
serum albumin and 10 mM glucose, with and 
without insulin for 24 h at 37’C [lo]. Then, 
isolated adipocytes from the tissues were tested for 
insulin-binding and glucose oxidation. 
3. RESULTS AND DISCUSSION 
Blood glucose and insulin values of rats after 14 
days administration of ADD-3878 are shown in 
table 1. Plasma insulin values were decreased in 
ADD-treated obese rats by the administration of 
the agent, suggesting that insulin sensitivity was in- 
creased in obese rats treated with ADD. 
Insulin-binding to isolated adipocytes from 
ADD-treated rats was comparable to that in non- 
treated rats as shown in table 1. Thus, administra- 
tion of the agents did not affect insulin receptors. 
In order to determine insulin action in these 
Table 1 
Characteristics of experimental animalsa 
Body weightb Plasma glucose’ Plasma insuhnc Bound insulin* 
(g) (mg/dU &units/ml) (%I 
Obese rats 
ADD-treated 
(n = 6) 
Non-treated 
(n = 6) 
Lean rats 
ADD-treated 
(n = 6) 
Non-treated 
(n = 6) 
Streptozotocin-treated rats 
ADD-treated 
(n = 4) 
Non-treated 
(n = 4) 
442 f 14 164zk 7 52 f 3d 4.1 f 0.3 
444rt 11 161 f 6 71 f 4 3.9 f 0.4 
212 f 10 124rt 5 32 f 3 3.5 + 0.3 
207 I: 8 126zf.z 3 31 * 4 3.3 + 0.4 
1‘76f 8 402 f 12 17 f 1 4.2 f 0.4 
L82k 7 410 + 10 16 i 1 4.3 f 0.2 
a Ali the values represent mean it SEM 
b Body weight represents the value on the day of experiment. Weight gain during 14 days treatment 
was comparable between ADD-treated and non-treated groups 
’ The values of plasma glucose and plasma insulin were the data of 9 a.m. on the day of experiment 
* Difference between ADD-treated and non-treated was statisti~lly signific~t 0, < 0.05) 
’ Insulin-binding to 2 x IO5 adipocytes from the rats after ADD-treatment or non-treatment for 14 
days. Differences between treated and non-treated groups were not statisticaIly significant. The- 
values indicate % bound at a trace concentration 
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adipocytes from ADD-treated obese rats, glucose 
uptake and glucose oxid~ion studies were per- 
formed. Fig.2 shows significantly increased 
glucose uptake and oxidation in isolated 
adipocytes from ADD-treated obese rats. 
Similar studies were performed on adipocytes 
from lean rats and streptozotocin-treated rats. 
Glucose oxidation was comparable in both ADD- 
treated and untreated streptozoto&in-treated rats 
(fig.3), indicating that the presence of a certain 
amount of insulin in the plasma was necessary for 
the effect of the agent to appear, and that the agent 
did not potentiate insulin action in the normal rats 
without insulin resistance and h~rinsulinemia. 
Fig.2. 2Deoxyglucose uptake (a) and glucose oxidation 
(b) in adipocytes from ADD-treated (0) or non-treated 
(o) obese rats. Data represent the mean f SEM of 6 
separate experiments for each analysis. Differences 
between two groups are statistically significant at all 
insulin con~ntrations @ < 0.05) except for the glucose 
oxidation study at the basal level (without insulin). 
insulin Concentration (ng/mO 
Fig.3. Glucose oxidation in adipocytes from ADD- 
treated (0) or non-treated (e) lean rats (---- ) and 
ADD-treated (0) or non-treated (0) streptozotocin- 
treated rats (- - -). Data represent he mean f SEM of 4 
separate experiments for each analysis. Differences 
between ADD-treated and non-treated groups were not 
statistically significant, 
Thus, ADD-3878 appeared to increase the effect of 
circulating insulin of the rats with hyperin- 
sulinemia and insulin resistance. Since the basal 
glucose uptake was elevated, the increased effect 
of circulating insulin may result in the increased 
capacity of glucose transport [l I]. 
To further characterize the potentiating effect of 
ADD, adipose tissues were cultured with the agent 
and insulin action on these cells were determined. 
In the absence of insulin in the culture media, no 
potentiating effect of ADD on insulin action was 
demonstrated in the culture system (fig.4a). 
However, in the presence of insulin (10 ng/ml), 
treatment with ADD-3878 increased glucose oxida- 
tion and potentiated insulin action in vitro (fig.4b). 
This result agreed with the study of streptozotocin- 
treated rats, suggesting that the agent itself was not 
able to increase glucose metabolism. Insulin- 
binding to adipocytes after the culture with insulin, 
no difference was shown between the ADD-treated 
and non-treated groups (fig.4c). Degradation of 
insulin during incubation was comparable between 
ADD-treated and non-treated groups (43.8 5~ 3.2% 
vs 41.6 + 4.190, mean + SEM). Therefore, the ef- 
fect of the agent appeared not to be related to a 
change of insulin receptors but related to the 
postreceptor process of insulin action. 
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FigA. Effect of ADD on insulin action in vitro: (a) 
Glucose oxidation in adipocyies after 24 h culture with 
(0) and without (0) ADD in the absence of insulin; (b) 
Glucose oxidation in adipocytes after 24 h culture with 
(0) and without (0) ADD in the presence of insulin 
(10 nglml). * Differences between two groups were 
stat~t~~ally significant @ < 0.05); (c) In~in-bln~~ to 
adipocytes after the culture condition of fi@b. 
Differences between the two groups were not statistically 
significant. 
The agent may act on the coupling process bet- 
ween receptors and effecters since no increased 
glucase oxidation was demonstrated at the basal 
level (without insulin) in the culture study, or it 
may be directly involved with the effector system. 
This agent may be usefuI to study the mechanism 
of post-receptor process of insulin action. Further- 
more, because of its unique mechanism to poten- 
tiate insulin’s effect in the insulin-resistant state, 
but not in normal or hypoinsulinemic conditions, 
it may be useful for treating Type-11 diabetic pa- 
tients, especially obese patients with 
h~e~nsulinemia. 
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